Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/111848
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Optometry-
dc.creatorChen, Y-
dc.creatorYang, S-
dc.creatorLiu, R-
dc.creatorXiong, R-
dc.creatorWang, Y-
dc.creatorLi, C-
dc.creatorZheng, Y-
dc.creatorHe, M-
dc.creatorWang, W-
dc.date.accessioned2025-03-18T01:13:10Z-
dc.date.available2025-03-18T01:13:10Z-
dc.identifier.issn0146-0404-
dc.identifier.urihttp://hdl.handle.net/10397/111848-
dc.language.isoenen_US
dc.publisherAssociation for Research in Vision and Ophthalmologyen_US
dc.rightsCopyright 2024 The Authorsen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/).en_US
dc.rightsThe following publication Yanping Chen, Shaopeng Yang, Riqian Liu, Ruilin Xiong, Yueye Wang, Cong Li, Yingfeng Zheng, Mingguang He, Wei Wang; Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm. Invest. Ophthalmol. Vis. Sci. 2024;65(6):40 is available at https://doi.org/10.1167/iovs.65.6.40.en_US
dc.subjectCohortsen_US
dc.subjectMachine learningen_US
dc.subjectMyopic macular degeneration (MMD)en_US
dc.subjectVisual impairmenten_US
dc.titleForecasting myopic maculopathy risk over a decade : development and validation of an interpretable machine learning algorithmen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume65-
dc.identifier.issue6-
dc.identifier.doi10.1167/iovs.65.6.40-
dcterms.abstractPURPOSE. The purpose of this study was to develop and validate prediction model for myopic macular degeneration (MMD) progression in patients with high myopia.-
dcterms.abstractMETHODS. The Zhongshan High Myopia Cohort for model development included 660 patients aged 7 to 70 years with a bilateral sphere of ≤−6.00 iopters (D). Two hundred twelve participants with an axial length (AL) ≥25.5 mm from the Chinese Ocular Imaging Project were used for external validation. Thirty-four clinical variables, including demographics, lifestyle, myopia history, and swept source optical coherence tomography data, were analyzed. Sequential forward selection was used for predictor selection, and binary classification models were created using five machine learning algorithms to forecast the risk of MMD progression over 10 years.-
dcterms.abstractRESULTS. Over a median follow-up of 10.9 years, 133 patients (20.2%) showed MMD progression in the development cohort. Among them, 69 (51.9%) developed newly-onset MMD, 11 (8.3%) developed patchy atrophy from diffuse atrophy, 54 (40.6%) showed an enlargement of lesions, and 9 (6.8%) developed plus signs. Top six predictors for MMD progression included thinner subfoveal choroidal thickness, longer AL, worse best-corrected visual acuity, older age, female gender, and shallower anterior chamber depth. The eXtreme Gradient Boosting algorithm yielded the best discriminative performance (area under the receiver operating characteristic curve [AUROC] = 0.87 ± 0.02) with good calibration in the training cohort. In a less myopic external validation group (median −5.38 D), 48 patients (22.6%) developed MMD progression over 4 years, with the model’s AUROC validated at 0.80 ± 0.008.-
dcterms.abstractCONCLUSIONS. Machine learning model effectively predicts MMD progression a decade ahead using clinical and imaging indicators. This tool shows promise for identifying “at-risk” high myopes for timely intervention and vision protection.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationInvestigative ophthalmology and visual science, June 2024, v. 65, no. 6, 40-
dcterms.isPartOfInvestigative ophthalmology and visual science-
dcterms.issued2024-06-
dc.identifier.scopus2-s2.0-85197200701-
dc.identifier.pmid38935031-
dc.identifier.eissn1552-5783-
dc.identifier.artn40-
dc.description.validate202503 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextHainan Province Clinical Medical Center; National Natural Science Foundation of China; Global STEM Professorship Schemeen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
i1552-5783-65-6-40_1719404850.98668.pdf3.52 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

66
Citations as of Feb 9, 2026

Downloads

48
Citations as of Feb 9, 2026

SCOPUSTM   
Citations

11
Citations as of May 8, 2026

WEB OF SCIENCETM
Citations

10
Citations as of Apr 23, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.